Tokyo Tape
Sign in
← Kaken Pharmaceutical

Quarterly report · Q1

4521.TEDINET S100OXC2
Period2022-04-01 → 2022-06-30
Filed2022-08-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥18.2bn2022-04-01 → 2022-06-30Cons.Net sales
Revenue¥76.0bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥18.5bn2021-04-01 → 2021-06-30Cons.Net sales
Operating income¥4.1bn2022-04-01 → 2022-06-30Cons.Operating income
Operating income¥4.4bn2021-04-01 → 2021-06-30Cons.Operating income
Ordinary income¥4.3bn2022-04-01 → 2022-06-30Cons.Ordinary income
Ordinary income¥17.5bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥4.7bn2021-04-01 → 2021-06-30Cons.Ordinary income
Profit before tax¥4.0bn2022-04-01 → 2022-06-30Cons.Income before income taxes
Profit before tax¥4.7bn2021-04-01 → 2021-06-30Cons.Income before income taxes
Net income (owners)¥2.9bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥9.5bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥3.4bn2021-04-01 → 2021-06-30Cons.Profit loss attributable to owners of parent
Net income¥2.9bn2022-04-01 → 2022-06-30Cons.Profit loss
Net income¥3.4bn2021-04-01 → 2021-06-30Cons.Profit loss
Total assets¥165.1bnat 2022-06-30Cons.Assets
Total assets¥165.2bnat 2022-03-31Cons.Assets
Total assets¥163.3bnat 2021-06-30Cons.Total assets (5-year summary)
Total liabilities¥27.2bnat 2022-06-30Cons.Liabilities
Total liabilities¥26.9bnat 2022-03-31Cons.Liabilities
Net assets / equity¥137.9bnat 2022-06-30Cons.Net assets
Net assets / equity¥138.3bnat 2022-03-31Cons.Net assets
Net assets / equity¥135.7bnat 2021-06-30Cons.Net assets (5-year summary)
Cash and deposits¥60.0bnat 2022-06-30Cons.Cash and deposits
Cash and deposits¥61.0bnat 2022-03-31Cons.Cash and deposits
EPS (basic)¥76.912022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥251.432021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥87.782021-04-01 → 2021-06-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio83.1%at 2022-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio83.4%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio83.1%at 2021-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
jpcrp040300-q1r_E00935-000Medicinereportable segmentrevenue2022-04-01 → 2022-06-30¥17.6bn
jpcrp040300-q1r_E00935-000Medicinereportable segmentrevenue external2022-04-01 → 2022-06-30¥17.6bn
jpcrp040300-q1r_E00935-000Medicinereportable segmentsegment profit2022-04-01 → 2022-06-30¥3.8bn
jpcrp040300-q1r_E00935-000Real Estatereportable segmentrevenue2022-04-01 → 2022-06-30¥615m
jpcrp040300-q1r_E00935-000Real Estatereportable segmentrevenue external2022-04-01 → 2022-06-30¥615m
jpcrp040300-q1r_E00935-000Real Estatereportable segmentsegment profit2022-04-01 → 2022-06-30¥295m
—segment totalrevenue2022-04-01 → 2022-06-30¥18.2bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥18.2bn
—segment totalsegment profit2022-04-01 → 2022-06-30¥4.1bn
jpcrp040300-q1r_E00935-000Medicinereportable segmentrevenue2021-04-01 → 2021-06-30¥17.9bn
jpcrp040300-q1r_E00935-000Medicinereportable segmentrevenue external2021-04-01 → 2021-06-30¥17.9bn
jpcrp040300-q1r_E00935-000Medicinereportable segmentsegment profit2021-04-01 → 2021-06-30¥4.1bn
jpcrp040300-q1r_E00935-000Real Estatereportable segmentrevenue2021-04-01 → 2021-06-30¥589m
jpcrp040300-q1r_E00935-000Real Estatereportable segmentrevenue external2021-04-01 → 2021-06-30¥589m
jpcrp040300-q1r_E00935-000Real Estatereportable segmentsegment profit2021-04-01 → 2021-06-30¥299m
—segment totalrevenue2021-04-01 → 2021-06-30¥18.5bn
—segment totalrevenue external2021-04-01 → 2021-06-30¥18.5bn
—segment totalsegment profit2021-04-01 → 2021-06-30¥4.4bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 372
ItemContextValueUnit
Bonuses and provision for bonuses sgaPrior1YTDDuration336000000JPY
Bonuses and provision for bonuses sgaCurrentYTDDuration307000000JPY
Retirement benefit expenses sgaPrior1YTDDuration93000000JPY
Retirement benefit expenses sgaCurrentYTDDuration85000000JPY
Research and development expenses sgaPrior1YTDDuration1865000000JPY
Research and development expenses sgaCurrentYTDDuration2030000000JPY
Other sgaPrior1YTDDuration2107000000JPY
Other sgaCurrentYTDDuration2153000000JPY
Selling general and administrative expensesPrior1YTDDuration5854000000JPY
Selling general and administrative expensesCurrentYTDDuration5983000000JPY
Operating incomePrior1YTDDuration4421000000JPY
Operating incomeCurrentYTDDuration4056000000JPY
Interest income noiPrior1YTDDuration1000000JPY
Interest income noiCurrentYTDDuration1000000JPY
Dividends income noiPrior1YTDDuration211000000JPY
Dividends income noiCurrentYTDDuration229000000JPY
Other noiPrior1YTDDuration37000000JPY
Other noiCurrentYTDDuration50000000JPY
Non operating incomePrior1YTDDuration250000000JPY
Non operating incomeCurrentYTDDuration281000000JPY
Interest expenses noePrior1YTDDuration4000000JPY
Interest expenses noeCurrentYTDDuration4000000JPY
Foreign exchange losses noePrior1YTDDuration1000000JPY
Foreign exchange losses noeCurrentYTDDuration－JPY
Other noePrior1YTDDuration5000000JPY
Other noeCurrentYTDDuration1000000JPY
Non operating expensesPrior1YTDDuration11000000JPY
Non operating expensesCurrentYTDDuration5000000JPY
Ordinary incomePrior1YTDDuration4660000000JPY
Ordinary incomeCurrentYTDDuration4332000000JPY
Other eiPrior1YTDDuration0JPY
Other eiCurrentYTDDuration0JPY
Extraordinary incomePrior1YTDDuration0JPY
Extraordinary incomeCurrentYTDDuration0JPY
Loss on retirement of noncurrent assets elPrior1YTDDuration4000000JPY
Loss on retirement of noncurrent assets elCurrentYTDDuration19000000JPY
Impairment loss elPrior1YTDDuration－JPY
Impairment loss elCurrentYTDDuration304000000JPY
Extraordinary lossPrior1YTDDuration4000000JPY
Extraordinary lossCurrentYTDDuration324000000JPY
Income before income taxesPrior1YTDDuration4655000000JPY
Income before income taxesCurrentYTDDuration4008000000JPY
Income taxesPrior1YTDDuration1292000000JPY
Income taxesCurrentYTDDuration1100000000JPY
Profit lossPrior1YTDDuration3362000000JPY
Profit lossCurrentYTDDuration2907000000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration－JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration－JPY
Profit loss attributable to owners of parentPrior1YTDDuration3362000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration2907000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass rounding
balance sheet identityconsolidated 2022-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass